Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Metabolic disorders, including obesity, diabetes, and cardiovascular disease, are widespread in Westernized nations. Gut microbiota composition is a contributing factor to the susceptibility of an individual to the development of these disorders; therefore, altering a person's microbiota may ameliorate disease. One potential microbiome-altering strategy is the incorporation of modified bacteria that express therapeutic factors into the gut microbiota. For example, N-acylphosphatidylethanolamines (NAPEs) are precursors to the N-acylethanolamide (NAE) family of lipids, which are synthesized in the small intestine in response to feeding and reduce food intake and obesity. Here, we demonstrated that administration of engineered NAPE-expressing E. coli Nissle 1917 bacteria in drinking water for 8 weeks reduced the levels of obesity in mice fed a high-fat diet. Mice that received modified bacteria had dramatically lower food intake, adiposity, insulin resistance, and hepatosteatosis compared with mice receiving standard water or control bacteria. The protective effects conferred by NAPE-expressing bacteria persisted for at least 4 weeks after their removal from the drinking water. Moreover, administration of NAPE-expressing bacteria to TallyHo mice, a polygenic mouse model of obesity, inhibited weight gain. Our results demonstrate that incorporation of appropriately modified bacteria into the gut microbiota has potential as an effective strategy to inhibit the development of metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While human and animal studies have established the ability to successfully populate the oral cavity or gastrointestinal tract with specific strains, combinations of bacteria, or bacteria genetically modified to produce enzymes or metabolites[74,404–407]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [406]
Experimental — accuracy not yet measuredIn the citing paper
“Chen et al. demonstrated that an N-acylphosphatidylethanolamine (NAPE)-producing strain of EcN could significantly ameliorate symptoms associated with high-fat diet feeding in mice. Mice treated with this recombinant EcN displayed reduced adiposity, insulin resistance, and hepatosteatosis compared to animals treated with an unengineered EcN control37.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“org Volume 124 Number 8 August 2014 Introduction Obesity dramatically increases the risks for cardiovascular disease and diabetes as well as other diseases, and rates of obesity have increased dramatically in the past 25 years (1, 2).”
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“Changes in global gut microbiota, including an increased ratio of Firmicutes to Bacteroidetes, have been associated with obesity (9, 36–38).”
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936 · cited 1×
“However, mutations in these genes are rare in humans and cause extreme forms of obesity (39–41).”
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
S UCCESSFUL W EIGHT L OSS M AINTENANCE
Wing, R. R., & Hill, J. O. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.323 · Cited by 1,382
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez de Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,064
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882
An anorexic lipid mediator regulated by feeding
Rodríguez de Fonseca, F., Navarro, M., Gómez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodríguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001) · Nature · doi:10.1038/35102582 · Cited by 694 · cited 1×
“Chronic NAE administration appears to modulate adiposity through multiple mechanisms including inhibition of fat absorption (25), delayed gastric emptying (26, 27), reduced food intake (19, 20, 28, 29), and increased fatty acid oxidation (23, 25).”
Diversity of the human skin microbiome early in life
Capone, K. A., Dowd, S. E., Stamatas, G. N., & Nikolovski, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.168 · Cited by 532
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Membrez, M., Blancher, F., Jaquet, M., Bibiloni, R., Cani, P. D., Burcelin, R. G., Corthesy, I., Macé, K., & Chou, C. J. (2008) · The FASEB Journal · doi:10.1096/fj.07-102723 · Cited by 493 · cited 2×
“One such alternative is suggested by studies showing a reciprocal relationship between the composition of the gut microbiota and metabolic disorders (7–13).”
The Results of Treatment for Obesity: A Review of the Literature and Report of a Series
STUNKARD, A. (1959) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1959.00270010085011 · Cited by 463
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429 · cited 1×
“The rapid metabolism of NAE by FAAH and NAAA likely accounts for this observation (46, 47).”
Swanson, K. S., Dowd, S. E., Suchodolski, J. S., Middelbos, I. S., Vester, B. M., Barry, K. A., Nelson, K. E., Torralba, M., Henrissat, B., Coutinho, P. M., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.162 · Cited by 420
(1989) · PubMed · Cited by 419
Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 399 · cited 1×
“NAE activation of GPR119 induces GLP-1 secretion (51, 52), and GLP-1 receptor agonists reduce food intake and fat accumulation on a high-fat diet (53, 54).”
Kramer, F. M., Jeffery, R. W., Forster, J. L., & Snell, M. K. (1989) · PubMed · Cited by 378
The Lipid Messenger OEA Links Dietary Fat Intake to Satiety
Schwartz, G. J., Fu, J., Astarita, G., Li, X., Gaetani, S., Campolongo, P., Cuomo, V., & Piomelli, D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.005 · Cited by 371 · cited 1×
“Importantly, NAEs fail to reduce food intake and body fat when PPAR α is genetically ablated (18, 28, 58).”
Lee, H.-Y., Park, J.-H., Seok, S.-H., Baek, M.-W., Kim, D.-J., Lee, K.-E., Paek, K.-S., Lee, Y., & Park, J.-H. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.05.007 · Cited by 342
Guzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404087200 · Cited by 328
Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats
An, H. M., Park, S. Y., Lee, D. K., Kim, J. R., Cha, M. K., Lee, S. W., Lim, H. T., Kim, K. J., & Ha, N. J. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-116 · Cited by 320
The worldwide diabetes epidemic
Lam, D. W., & LeRoith, D. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328350583a · Cited by 316 · cited 1×
“org Volume 124 Number 8 August 2014 Introduction Obesity dramatically increases the risks for cardiovascular disease and diabetes as well as other diseases, and rates of obesity have increased dramatically in the past 25 years (1, 2).”
Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
Harris, K., Kassis, A., Major, G., & Chou, C. J. (2012) · Journal of Obesity · doi:10.1155/2012/879151 · Cited by 276 · cited 1×
“One such alternative is suggested by studies showing a reciprocal relationship between the composition of the gut microbiota and metabolic disorders (7–13).”
Fu, J., Oveisi, F., Gaetani, S., Lin, E., & Piomelli, D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.013 · Cited by 276
Ho, W., Barrett, D. A., & Randall, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.324 · Cited by 259
Activation of TRPV1 by the Satiety Factor Oleoylethanolamide
Ahern, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305051200 · Cited by 257
Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine
Fu, J., Astarita, G., Gaetani, S., Kim, J., Cravatt, B. F., Mackie, K., & Piomelli, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607809200 · Cited by 244 · cited 2×
“NAPEs are synthesized in the proximal small intestine in response to feeding (14).”
Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice
Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y., & Park, H.-O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054617 · Cited by 230
Wang, X., Miyares, R. L., & Ahern, G. P. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.081844 · Cited by 195 · cited 2×
“NAEs act as ligands for at least 3 receptors: PPAR α , TRPV1, and GPR119 (23, 28, 30), and genetic ablation of PPAR α or TRPV1 significantly blunts the anorectic effects of NAEs (28, 31).”
Regulation of food intake by oleoylethanolamide
Lo Verme, J., Gaetani, S., Fu, J., Oveisi, F., Burton, K., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 169
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.02.003 · Cited by 166
Fåk, F., & Bäckhed, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046837 · Cited by 166
N-acylethanolamines, anandamide and food intake
Hansen, H. S., & Diep, T. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.024 · Cited by 164
Leptin and leptin receptor-related monogenic obesity
Dubern, B., & Clément, K. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.010 · Cited by 159
Modulation of Meal Pattern in the Rat by the Anorexic Lipid Mediator Oleoylethanolamide
Gaetani, S., Oveisi, F., & Piomelli, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300166 · Cited by 159 · cited 1×
“Within the intestinal tract, we found that pNAPE-EcN admin-Figure (48–50).”
Genetic Analysis of a New Mouse Model for Non-Insulin-Dependent Diabetes
Kim, J. H., Sen, Ś., Avery, C. S., Simpson, E., Chandler, P., Nishina, P. M., Churchill, G. A., & Naggert, J. K. (2001) · Genomics · doi:10.1006/geno.2001.6569 · Cited by 158
Mack, C. M., Moore, C. X., Jodka, C. M., Bhavsar, S., Wilson, J. K., Hoyt, J. A., Roan, J. L., Vu, C., Laugero, K. D., Parkes, D. G., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803284 · Cited by 152
Gillum, M. P., Zhang, D., Zhang, X.-M., Erion, D. M., Jamison, R. A., Choi, C., Dong, J., Shanabrough, M., Duenas, H. R., Frederick, D. W., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.043 · Cited by 142
Regulation of GPR119 receptor activity with endocannabinoid-like lipids
Syed, S. K., Bui, H. H., Beavers, L. S., Farb, T. B., Ficorilli, J., Chesterfield, A. K., Kuo, M.-S., Bokvist, K., Barrett, D. G., & Efanov, A. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00269.2012 · Cited by 120 · cited 1×
“NAE activation of GPR119 induces GLP-1 secretion (51, 52), and GLP-1 receptor agonists reduce food intake and fat accumulation on a high-fat diet (53, 54).”
Heterologous protein secretion and the versatile Escherichia coli haemolysin translocator
Blight, M. A., & Holland, I. B. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90020-5 · Cited by 119
Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse
Andersson, U., Bränning, C., Ahrné, S., Molin, G., Alenfall, J., Önning, G., Nyman, M., & Holm, C. (2010) · Beneficial Microbes · doi:10.3920/bm2009.0036 · Cited by 115
Larsen, P. J., Jensen, P. B., Sørensen, R. V., Larsen, L. K., Vrang, N., Wulff, E. M., & Wassermann, K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2249 · Cited by 111
Fu, J., Kim, J., Oveisi, F., Astarita, G., & Piomelli, D. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00126.2008 · Cited by 106
Majander, K., Anton, L., Antikainen, J., Lång, H. A., Brummer, M. H., Korhonen, T., & Westerlund‐Wikström, B. (2005) · Nature Biotechnology · doi:10.1038/nbt1077 · Cited by 105
Terrazzino, S., Berto, F., Carbonare, M. D., Fabris, M., Guiotto, A., Bernardini, D., & Leon, A. (2004) · The FASEB Journal · doi:10.1096/fj.03-1080fje · Cited by 105
Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice
Kim, J. H., Stewart, T. P., Soltani-Bejnood, M., Wang, L., Fortuna, J. M., Mostafa, O. A., Moustaid-Moussa, N., Shoieb, A. M., McEntee, M. F., Wang, Y., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06647 · Cited by 104 · cited 2×
“Female TallyHo mice have been reported to rapidly gain excess weight and body fat (relative to C57BL6J mice) in the first 12 weeks of life, even while consuming a standard chow diet and without displaying the hyperglycemia seen in male TallyHo mice (45).”
InfluentialFood intake is inhibited by oral oleoylethanolamide
Nielsen, M. J., Petersen, G., Astrup, A., & Hansen, H. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c300008-jlr200 · Cited by 103 · cited 1×
“Chronic NAE administration appears to modulate adiposity through multiple mechanisms including inhibition of fat absorption (25), delayed gastric emptying (26, 27), reduced food intake (19, 20, 28, 29), and increased fatty acid oxidation (23, 25).”
Petersen, G. L., Sørensen, C., Schmid, P. C., Artmann, A., Tang‐Christensen, M., Hansen, S. H., Larsen, P. J., Schmid, H. H. O., & Hansen, H. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.011 · Cited by 102
Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration
Oveisi, F. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.006 · Cited by 100
Mileykovskaya, E., Ryan, A. C., Mo, X., Lin, C., Khalaf, K. I., Dowhan, W., & Garrett, T. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805189200 · Cited by 88
Characterization of the Hyperphagic Response to Dietary Fat in the MC4R Knockout Mouse
Srisai, D., Gillum, M. P., Panaro, B. L., Zhang, X., Kotchabhakdi, N., Shulman, G. I., Ellacott, K. L. J., & Cone, R. D. (2011) · Endocrinology · doi:10.1210/en.2010-0716 · Cited by 80
The TALLYHO Mouse as a Model of Human Type 2 Diabetes
Kim, J. H., & Saxton, A. M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-068-7_6 · Cited by 75
Harrington, W. W., Britt, C. S., Wilson, J. G., Milliken, N. O., Binz, J. G., Lobe, D. C., Oliver, W. R., Lewis, M. C., & Ignar, D. M. (2007) · PPAR Research · doi:10.1155/2007/97125 · Cited by 74
Aviello, G., Matias, I., Capasso, R., Petrosino, S., Borrelli, F., Orlando, P., Romano, B., Capasso, F., Marzo, V. D., & Izzo, A. A. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0305-7 · Cited by 73 · cited 1×
“Chronic NAE administration appears to modulate adiposity through multiple mechanisms including inhibition of fat absorption (25), delayed gastric emptying (26, 27), reduced food intake (19, 20, 28, 29), and increased fatty acid oxidation (23, 25).”
Astrup, A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00894.x · Cited by 66
Leiter, E. H., Strobel, M., O'Neill, A., Schultz, D., Schile, A., & Reifsnyder, P. C. (2013) · Journal of Diabetes Research · doi:10.1155/2013/165327 · Cited by 56
Cluny, N. L., Keenan, C. M., Lutz, B., Piomelli, D., & Sharkey, K. A. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01248.x · Cited by 56
Thabuis, C., Destaillats, F., Lambert, D. M., Muccioli, G. G., Maillot, M., Harach, T., Tissot-Favre, D., & Martin, J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013391 · Cited by 50
Schmidt, S. L., Kealey, E. H., Horton, T. J., VonKaenel, S., & Bessesen, D. H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.202 · Cited by 40
Thabuis, C., Destaillats, F., Landrier, J., Tissot-Favre, D., & Martin, J. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.07.006 · Cited by 39 · cited 1×
“Chronic NAE administration appears to modulate adiposity through multiple mechanisms including inhibition of fat absorption (25), delayed gastric emptying (26, 27), reduced food intake (19, 20, 28, 29), and increased fatty acid oxidation (23, 25).”
Guo, L., Amarnath, V., & Davies, S. S. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.06.027 · Cited by 36 · cited 2×
“This markedly increased NAPE levels in these bacteria (pNAPE-Ec) compared with those transformed with empty vector (pEc) (32, 33).”
Self-citationBrown, W. H., Gillum, M. P., Lee, H.-Y., Camporez, J. P. G., Zhang, X.-M., Jeong, J. K., Alves, T. C., Erion, D. M., Guigni, B. A., Kahn, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212887109 · Cited by 35 · cited 2×
“Of note, our finding that elevations of NAEs in the liver corresponded with slightly increased resting energy expenditure contrasts with a recent study that found decreased resting energy expenditure when NAE levels were elevated systematically by genetic ablation of fatty acid amide hydrolase or by subcutaneous infus…”
Tatarkiewicz, K., Sablan, E. J., Polizzi, C. J., Villescaz, C., & Parkes, D. G. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00495.2013 · Cited by 31
Horn, C. C., Jonghe, B. C. D., Mátyás, K., & Norgren, R. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00284.2009 · Cited by 31 · cited 1×
“We also measured consumption of kaolin (pica), a measure of gastrointestinal distress in rodents (35), to assess whether bacterial administration had an adverse effect on the mice.”
Buddenborg, C., Daudel, D., Liebrecht, S., Greune, L., Humberg, V., & Schmidt, M. A. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.08.008 · Cited by 31
Bulat, E., & Garrett, T. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269779 · Cited by 29
Rolland, V., Clément, K., Dugail, I., Guy-grand, B., Basdevant, A., Froguel, P., & Lavau, M. M. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00325.x · Cited by 29
Discovery and Characterization of an Arabidopsis thaliana N-Acylphosphatidylethanolamine Synthase
Faure, L., Coulon, D., Laroche‐Traineau, J., Guédard, M. L., Schmitter, J., Testet, E., Lessire, R., & Bessoule, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005744 · Cited by 26 · cited 2×
“This markedly increased NAPE levels in these bacteria (pNAPE-Ec) compared with those transformed with empty vector (pEc) (32, 33).”
Self-citationGenetically ModifiedLactococcus lactisfor Delivery of Human Interleukin-10 to Dendritic Cells
Huibregtse, I. L., Zaat, S. A., Kapsenberg, M. L., da Silva, M. A. S., Peppelenbosch, M. P., van Deventer, S. J. H., & Braat, H. (2011) · Gastroenterology Research and Practice · doi:10.1155/2012/639291 · Cited by 25
Perreault, M., Will, S., Panza, D., Gareski, T., Harding, K., Kubasiak, D., Jalenak, M., Gartrell, K., Wang, S., Bollag, G. E., et al. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01157.x · Cited by 12 · cited 1×
“NAEs are also potent PPAR α agonists, and PPAR α agonists reduce long-term food intake and fat accumulation, while also increasing fatty acid oxidation (55–57).”
Research works printed but not linked: 3
- Kramer, 1989, Int J Obes., 13, 123
- Wadden, 1989, Int J Obes., 13, 39
- Harris, 2012, J Obes., 2012, 879151
Cited by
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Impacts of gut bacteria on human health and diseases
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047493 · Cited by 1,055
Self-citationThe host shapes the gut microbiota via fecal microRNA
Liu, S., da Cunha, A. P., Rezende, R. M., Cialic, R., Wei, Z., Bry, L., Comstock, L. E., Gandhi, R., & Weiner, H. L. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.005 · Cited by 808
“, 2011) and metabolism (Chen et al., 2014), including SFB, E.”
Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4222 · Cited by 605
Metadata
- Authors
- Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., Coulon, D., McGuinness, O. P., Niswender, K. D., & Davies, S. S.
- Affiliations
- Vanderbilt University (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Davies, Sean S.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-06-24
- Volume
- 124
- Issue
- 8
- Pages
- 3391-3406
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4109548
- OpenAlex
- W2076877166
- Cited by
- 277
- References
- 76
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 19 · 2023: 22 · 2022: 31 · 2021: 26 · 2020: 26 · 2019: 22 · 2018: 18 · 2017: 35 · 2016: 29 · 2015: 23 · 2014: 3
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Funders
- National Institutes of Health (1dp2od003137-01, 5p60dk020593-31)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK020593, U24DK092993, DK59637, DK 20593, U24DK059637, P30DK058404, P30DK020593)
- National Center for Research Resources (UL1RR024975)
- National Center for Complementary and Integrative Health (R01AT007830, AT07830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- obesity, gut microbiota, engineered bacteria, N-acylphosphatidylethanolamine, Escherichia coli Nissle 1917, high-fat diet, dietary intake, insulin resistance, hepatic steatosis, metabolic disorders, microbiome engineering
- MeSH terms
- Acyltransferases, Animals, Digestive System, Disease Models, Animal, DNA-Binding Proteins, Eating, Escherichia coli, Female, Humans, Liver, Male, Mice, Inbred C57BL, Obesity, Phosphatidylethanolamines, Recombinant Proteins, Weight Gain, Arabidopsis Proteins, Mice, Diet, High-Fat, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.